Belgium· BE-AMP-SAM202447-00
Insuman Basal 100 IU/ml
A insulin (human) product containing insulin isophane protamine human, registered in Belgium by Sanofi-Aventis Deutschland. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Insulin (human) is registered in 11 of 19 countries.
Countries holding a registration under ATC A10AB01 (insulin (human)), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Insulin (human) · ATC A10AB01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Insulin Isophane Protamine Human
- Manufacturer
- Sanofi-Aventis Deutschland
- Country
- Belgium (BE)
- ATC code
- A10AB01
- ATC class
- Insulin (human)
- Defined daily dose
- 40 E, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0797639
- be_apb2688968
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
461 interactions on record for insulin (human).
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Insulin (human) · interactions on record
461 records
- 15 severe
- 395 moderate
- 50 minor
Most severe, free to view
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- PrednisoloneA07EA01moderate
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A10AB01
Insulin (human), as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a95d9f5f-9384-403b-ae7a-d43620b756bc GET /v1/drugs/a95d9f5f-9384-403b-ae7a-d43620b756bc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Suspension for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Insuman Basal 100 IU/ml",
"name_fr": "Insuman Basal 100 IU/ml",
"name_nl": "Insuman Basal 100 IU/ml",
"amp_code": "SAM202447-00",
"strengths": [
"100.0000"
],
"pack_count": 2,
"substances": [
"Insulin Isophane Protamine Human",
"Glycerol",
"Sodium Dihydrogen Phosphate Dihydrate",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Insulin (Human)",
"authorisation_numbers": [
"EU/1/97/030/033",
"EU/1/97/030/034"
]
}See everything about insulin (human).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.